173 related articles for article (PubMed ID: 37965463)
1. PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma.
Al-Ghazzawi K; Wessolly M; Dalbah S; Ketteler P; Kiefer T; Bechrakis N; Leyla J; Ting S; Biewald E; Mairinger FD
Front Oncol; 2023; 13():1144951. PubMed ID: 37965463
[TBL] [Abstract][Full Text] [Related]
2. Erratum: PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma.
Frontiers Production Office
Front Oncol; 2023; 13():1339187. PubMed ID: 38144526
[TBL] [Abstract][Full Text] [Related]
3. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
Mirzayev I; Gündüz AK; Yavuz K; Şekkeli MZ; Özalp Ateş FS; Ünal E; Taçyıldız N
Eur J Ophthalmol; 2021 Sep; 31(5):2692-2698. PubMed ID: 32962409
[TBL] [Abstract][Full Text] [Related]
4. Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.
Selzer EB; Welch RJ; Jabbour P; Leahey AM; Shields CL
Indian J Ophthalmol; 2019 Dec; 67(12):2005-2011. PubMed ID: 31755439
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
6. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment.
Munier FL; Mosimann P; Puccinelli F; Gaillard MC; Stathopoulos C; Houghton S; Bergin C; Beck-Popovic M
Br J Ophthalmol; 2017 Aug; 101(8):1086-1093. PubMed ID: 27927678
[TBL] [Abstract][Full Text] [Related]
7. [ADVANCES IN THE TREATMENT OF RETINOBLASTOMA AT HADASSAH IN THE LAST THREE DECADES].
Frenkel S; Weintraub M; Rot I; Shoshani N; Pe'er J
Harefuah; 2018 Mar; 157(3):149-153. PubMed ID: 29582943
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma.
Han JW; Lee CS; Hahn SM; Ahn WK; Kim HS; Yun H; Lee SC; Kim BM; Kim DJ; Lyu CJ
Cancer Res Treat; 2023 Jan; 55(1):270-278. PubMed ID: 35609621
[TBL] [Abstract][Full Text] [Related]
9. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):723-730. PubMed ID: 32123960
[TBL] [Abstract][Full Text] [Related]
10. Retinoblastoma: achieving new standards with methods of chemotherapy.
Kaliki S; Shields CL
Indian J Ophthalmol; 2015 Feb; 63(2):103-9. PubMed ID: 25827539
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
[TBL] [Abstract][Full Text] [Related]
12. [Pay attention to the application of the international intraocular retinoblastoma classification and sequential multiple modality treatment].
Fan XQ
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):561-565. PubMed ID: 28851194
[TBL] [Abstract][Full Text] [Related]
13. Targeted chemotherapy in retinoblastoma: A step forward from patient survival to globe survival.
Naseripour M; Sedaghat A; Mirshahi R; Abdolalizadeh P; Koushki A; Faranoush M; Ghorbani M; Kashkouli MB; Sadeghipour A; Chaibakhsh S; Mehrvar A
Eur J Ophthalmol; 2023 Jan; 33(1):574-586. PubMed ID: 35414292
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.
Kumari N; Jain N; Saboo S; Parthasarathy R; Gupta V; Mahajan A; Das S
Indian J Ophthalmol; 2023 Feb; 71(2):436-443. PubMed ID: 36727336
[TBL] [Abstract][Full Text] [Related]
15. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Huang W; Jiang H; Xia J; Zhang S
BMC Cancer; 2018 Apr; 18(1):486. PubMed ID: 29703164
[TBL] [Abstract][Full Text] [Related]
16. The management of retinoblastoma.
Fabian ID; Onadim Z; Karaa E; Duncan C; Chowdhury T; Scheimberg I; Ohnuma SI; Reddy MA; Sagoo MS
Oncogene; 2018 Mar; 37(12):1551-1560. PubMed ID: 29321667
[TBL] [Abstract][Full Text] [Related]
17. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage.
Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
Ophthalmology; 2020 Dec; 127(12):1733-1746. PubMed ID: 32526306
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
Xing L; Zhang L; Feng Y; Cui Z; Ding L
Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
[TBL] [Abstract][Full Text] [Related]
19. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
20. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
Alkatan HM; AlQahtani FS; Maktabi AM
Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
